Research progress on drug resistance mechanism of Candida glabrata / 药学实践杂志
Journal of Pharmaceutical Practice
; (6): 393-395, 2023.
Article
in Zh
| WPRIM
| ID: wpr-978474
Responsible library:
WPRO
ABSTRACT
With the increasing proportion of Candida glabrata in patients with candidiasis, C. glabrata has become one of the most common pathogenic Candida in clinical practice. There are limited types of antifungal drugs, and the consequent problem of drug resistance is severely increasing, which brings difficulties to clinical treatment. The resistance mechanisms of C. glabrata to azoles, echinocandins and polyenes were reviewed in this paper.
Full text:
1
Index:
WPRIM
Language:
Zh
Journal:
Journal of Pharmaceutical Practice
Year:
2023
Type:
Article